Sensus Healthcare, Inc. - Common Stock, $0.01 par value (SRTS)

Historical Holders from Q3 2016 to Q3 2025

Symbol
SRTS on Nasdaq
Type / Class
Equity / Common Stock, $0.01 par value
Shares outstanding
16,385,263
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
4,213,544
Holdings value
$13,235,817
% of all portfolios
0%
Number of holders
42
Number of buys
13
Number of sells
-21
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Sensus Healthcare, Inc. - Common Stock, $0.01 par value (SRTS)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Solot Edwin Lee 7.6% $5,827,910 1,245,280 Edwin L. Solot, Jr. 31 Dec 2024

Institutional Holders of Sensus Healthcare, Inc. - Common Stock, $0.01 par value (SRTS)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 4,213,544 $13,235,817 -$716,846 $3.14 42
2025 Q2 4,345,464 $20,596,029 +$1,512,062 $4.74 46
2025 Q1 4,026,834 $19,046,437 -$6,276,532 $4.73 53
2024 Q4 4,903,533 $33,920,348 +$6,954,088 $6.92 65
2024 Q3 3,885,568 $22,593,506 +$3,373,159 $5.8 50
2024 Q2 3,273,489 $17,552,838 +$4,434,599 $5.33 47
2024 Q1 2,481,212 $9,277,180 -$140,014 $3.8 45
2023 Q4 2,617,403 $6,188,682 -$467,743 $2.36 40
2023 Q3 2,661,310 $7,368,535 -$2,226,146 $2.77 40
2023 Q2 3,414,591 $10,755,535 -$7,918,322 $3.15 49
2023 Q1 4,900,010 $25,524,883 -$1,697,795 $5.21 66
2022 Q4 5,076,199 $37,640,159 -$13,766,550 $7.42 66
2022 Q3 6,115,199 $76,605,789 +$14,256,431 $12.53 77
2022 Q2 5,091,341 $39,116,200 +$6,033,503 $7.68 56
2022 Q1 4,419,085 $44,720,750 +$21,822,621 $10.12 53
2021 Q4 2,277,916 $16,438,000 +$8,095,278 $7.22 37
2021 Q3 1,309,389 $4,714,000 +$14,842 $3.6 18
2021 Q2 1,302,714 $5,014,000 -$279,059 $3.85 18
2021 Q1 1,376,215 $5,267,000 +$241,320 $3.82 20
2020 Q4 1,312,808 $5,067,000 +$189,276 $3.86 17
2020 Q3 1,267,945 $3,195,000 -$285,048 $2.52 20
2020 Q2 1,140,216 $3,499,000 -$583,507 $3.06 17
2020 Q1 1,604,962 $4,013,000 -$402,172 $2.5 19
2019 Q4 1,749,713 $6,193,000 -$362,070 $3.54 20
2019 Q3 1,700,318 $10,203,000 -$503,691 $6 16
2019 Q2 1,785,935 $9,893,000 -$395,687 $5.54 15
2019 Q1 1,791,299 $12,574,000 +$3,269,059 $7.02 22
2018 Q4 1,324,776 $9,814,000 -$8,568,638 $7.4 13
2018 Q3 2,324,079 $19,475,000 +$7,626,156 $8.38 22
2018 Q2 1,414,057 $10,267,000 +$2,375,622 $7.26 13
2018 Q1 1,113,727 $6,731,000 +$154,381 $5.84 12
2017 Q4 1,087,249 $5,641,000 -$228,141 $5.17 11
2017 Q3 1,134,209 $5,647,000 +$274,216 $4.98 13
2017 Q2 1,089,976 $4,382,000 +$405,660 $4.02 10
2017 Q1 1,195,758 $5,249,000 +$397,231 $4.39 12
2016 Q4 1,105,095 $5,792,000 +$347,849 $5.25 10
2016 Q3 1,038,642 $6,387,000 +$6,387,000 $6.15 9